Claritev Corp

Claritev Corp is a U.S.-based healthcare technology and services company that helps payers and plan sponsors manage medical cost, payment accuracy, and revenue integrity. Its platform combines out-of-network cost management, provider network access, data and decision science, and business-to-business healthcare payments to improve transparency, affordability, and quality across the healthcare ecosystem.

13,5 %

−29,4 %

+3,7 %

0.86

0.86

— Claritev Corp
%
Claims Intelligence Solutions35% Tools that help payers manage medical spend, billing accuracy, and claim payment integrity.
Network Solutions30% Primary and complementary PPO network access and provider discount arrangements.
Payment and Revenue Integrity20% Services that improve reimbursement accuracy and reduce payment errors across claims workflows.
Data and Decision Science10% Analytics and proprietary data products used to support pricing, transparency, and cost management.
Healthcare Payments and Other Services5% Transaction and payment-related services sold through healthcare payer channels.

Claritev sells primarily to healthcare payers, especially ASOs, TPAs, health insurers, and regional or national plans...

  • ASOs and TPAsprimary

    They buy wholesale claims and network solutions to serve self-insured employer clients and reduce medical cost burden.

  • Health insurers and Blue plansprimary

    They use Claritev's network, payment integrity, and claims intelligence offerings to improve reimbursement accuracy and manage spend.

  • Self-insured employers and plan sponsorsprimary

    They are the end customers behind the ASO channel and use the solutions to control healthcare costs and improve member access.

  • Government-sponsored health planssecondary

    They buy cost-management and payment solutions to support public-plan administration and claims accuracy.

  • P&C and supplemental insurerssecondary

    They use bill review and claims-adjudication-related services where healthcare payment accuracy is important.

Claritev's business is primarily U.S.-focused, with its solutions sold nationally through payer and employer...

  • United States is the core market and main revenue base
  • Solutions are distributed nationally through payer and ASO channels
  • International expansion is a stated strategic priority
  • Provider network scale is a U.S. competitive asset
  • New markets must fit similar healthcare cost and payment challenges

Claritev's Vision 2030 strategy is to evolve from a claims-cost management provider into a broader technology and data...

01
Grow core claims and network solutionsshort-term

The company wants to deepen value from its installed base and improve monetization of existing client relationships.

02
Expand adjacent productsmedium-term

Using the same data and distribution channels can raise TAM without rebuilding the go-to-market model.

03
International market entrymedium-term

New geographies could diversify revenue and apply the platform to similar healthcare affordability problems.

04
Operational and financial transformationshort-term

Management is trying to improve execution, efficiency, and scalability as the company returns to growth.

Claritev is exposed to customer concentration risk because a small number of large clients account for a meaningful...

high

Customer concentration

Two or three clients represented a large share of revenue in recent periods, so churn would hit revenue and operating leverage.

Scope
Top payer and ASO clients
Materiality
high
high

Cybersecurity and privacy breach

The business processes sensitive healthcare and claims data, so a breach could disrupt operations and damage trust.

Scope
Client data, claims files, payment workflows
Materiality
high
high

IT system downtime or software license disruption

Clients rely on uninterrupted access for time-sensitive claims processing, so outages can trigger switching behavior.

Scope
Transaction processing and client integrations
Materiality
high
medium

International expansion execution

The company is entering markets where it has limited operating history and may need localized products and staffing.

Scope
New geographies and languages
Materiality
medium
Revenue recognition
Can shift revenue between periods and affect gross margin comparability
Goodwill and long-lived asset impairment
Could reduce earnings and book value materially
Fair value measurements
Can create earnings volatility unrelated to core operations
Debt and interest expense
Raises leverage burden and depresses net income
Income taxes and transformation costs
Can obscure underlying operating trend

: 28.4.2026